Indeed, in nonfunctioning PitNET the efficacy of the chimeric compound BIM-23A760 is mainly dependent on D2DR activation (73), although no correlation has been found between D2DR expression and the sensitivity to BIM-23A760 in this pituitary tumor model (73). Here, DRD2 is linked to pituitary tumor.